Page last updated: 2024-08-16

ribavirin and Carcinoma, Epidermoid

ribavirin has been researched along with Carcinoma, Epidermoid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dunn, LA; Fury, MG; Haque, SS; Ho, AA; Katabi, N; Pfister, DG; Sherman, EJ	1
Chen, H; Dai, D; Tang, J; Tang, Y	1
Dimery, IW; Hong, WK; Krakoff, IH; McCarthy, K; Neidhart, JA	1

Trials

2 trial(s) available for ribavirin and Carcinoma, Epidermoid

Article	Year
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer. Head & neck, 2018, Volume: 40, Issue:2 Topics: Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Ribavirin	2018
Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck. Cancer treatment reports, 1987, Volume: 71, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ribavirin; Ribonucleosides	1987

Article

Year

Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.

Head & neck, 2018, Volume: 40, Issue:2

Topics: Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Ribavirin

2018

Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.

Cancer treatment reports, 1987, Volume: 71, Issue:4

Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ribavirin; Ribonucleosides

1987

Other Studies

1 other study(ies) available for ribavirin and Carcinoma, Epidermoid

Article	Year
Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma. Biochemical and biophysical research communications, 2017, Jan-22, Volume: 482, Issue:4 Topics: Animals; Antimetabolites; Antiviral Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Nucleocytoplasmic Transport Proteins; Paclitaxel; Ribavirin; Signal Transduction; Tongue Neoplasms; TOR Serine-Threonine Kinases	2017

Article

Year

Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma.

Biochemical and biophysical research communications, 2017, Jan-22, Volume: 482, Issue:4

Topics: Animals; Antimetabolites; Antiviral Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Nucleocytoplasmic Transport Proteins; Paclitaxel; Ribavirin; Signal Transduction; Tongue Neoplasms; TOR Serine-Threonine Kinases

2017